PATENT CLAIM ANALYSIS

Application Number: 15764687
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "480000"]

Abstract:
Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, and allergic, autoimmune, and inflammatory disorders including hematological malignancies. In particular, the methods include administration of a BTK inhibitor and with one or more inhibitor. For example, the one or more inhibitor may be a JAK inhibitor, a ASK1 inhibitor, a BRD4 inhibitor or an MMP9 inhibitor.

Claim (Index 5):
The method of  claim 1  wherein the human is in refractory to at least one of the cancer therapies, or is in relapse after treatment with at least one anti-cancer therapy selected from the group consisting of: (a) fludarabine; (b) rituximab; (c) rituximab combined with fludarabine; (d) cyclophosphamide combined with fludarabine; (e) cyclophosphamide combined with rituximab and fludarabine; (f) cyclophosphamide combined with vincristine and prednisone; (g) cyclophosphamide combined with vincristine, prednisone, and rituximab; (h) a combination of cyclophosphamide, doxorubicin, vincristine, and prednisone; (i) Chlorambucil combined with prednisone, rituximab, obinutuzumab, or ofatumumab; (j) pentostatin combined with cyclophosphamide and rituximab, (k) bendamustine (Treanda\u00ae) combined with rituximab; (l) alemtuzumab; (m) fludarabine plus cyclophosphamide, bendamustine, or chlorambucil; and (n) fludarabine plus cyclophosphamide, bendamustine, or chlorambucil, combined with an anti-CD20 antibody.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.61364
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319740', '14135812', '15105372', '14254010', '14570655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8002898650374117
- 35 USC 102 Novelty (BERT): 0.5140724717067942
- Combined Prediction Score: 0.7716681257043501
- Mean Citation Score: 247.382998
- Max Citation Score: 260.51425
- Similarity Product: 152.25794329841438

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test